About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds
I was like, oh my God, what happens if it doesn’t work’? Young people living with HIV, clinical trial participation and the truth economy
Raltegravir in HIV-1 Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy